Trial Radar IA | ||
|---|---|---|
Lo studio clinico NCT07398443 (MATEY) per Economia comportamentale, Fumo di cannabis, Fumo di tabacco è in arruolamento. Consulti la vista a schede del Radar degli Studi Clinici e gli strumenti di scoperta IA per tutti i dettagli. Oppure, ponga pure una domanda qui. | ||
Un studio corrisponde ai criteri del filtro
Vista a schede
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults (MATEY) 120 Innovativo
I dettagli dello studio clinico sono disponibili principalmente in inglese. Tuttavia, Trial Radar IA può essere d'aiuto! Basta cliccare su 'Spiega lo studio' per visualizzare e discutere le informazioni sullo studio nella lingua selezionata.
La sperimentazione clinica NCT07398443 (MATEY) è uno studio interventistico per Economia comportamentale, Fumo di cannabis, Fumo di tabacco, attualmente in arruolamento. Avviato il 17 febbraio 2026, prevede di arruolare 120 partecipanti. Sotto la guida di l'Università Brown, dovrebbe concludersi entro il 30 novembre 2028. I dati più recenti da ClinicalTrials.gov sono stati aggiornati l'ultima volta il 4 marzo 2026.
Sommario breve
The multi session experimental study aims to determine dual use patterns of marijuana and tobacco by assessing the impact of price and availability of marijuana and tobacco using a cross price elasticity of demand task. The study will recruit 120 non-treatment seeking emerging young adults (18-25 years) who smoke marijuana and tobacco.
Descrizione dettagliata
Young adulthood is a crucial time to study substance use disorders which increase cancer risk later in life. It is especially important to understand marijuana and tobacco use as most young adults often use both. Although dual use is related with increased long-term health and behavioral risks, underlying behavioral mechanisms remain unclear. This study aims to address this gap by using rigorous laboratory-based beha...Mostra di più
Titolo ufficiale
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
Patologie
Economia comportamentaleFumo di cannabisFumo di tabaccoAltri ID dello studio
- MATEY
- 00000691
- R01CA289409 (Sovvenzione/Contratto NIH (USA))
Numero NCT
Data di inizio (effettiva)
2026-02-17
Ultimo aggiornamento pubblicato
2026-03-04
Data di completamento (stimata)
2028-11-30
Arruolamento (previsto)
120
Tipo di studio
Interventistico
FASE
N.D.
Stato
In arruolamento
Scopo principale
Ricerca di base
Allocazione
N.D.
Modello di intervento
A gruppo singolo
Mascheramento
Nessuno (studio in aperto)
Bracci / Interventi
| Gruppo/Braccio di partecipanti | Intervento/Trattamento |
|---|---|
SperimentaleCue Reactivity Participants will be exposed to neutral followed by cannabis or tobacco cues in a fixed sequence while they answer questions about their subjective state. The cues will include everyday items (e.g., eraser) and cannabis-related items (e.g., lighter). | Cue Reactivity Participants will be exposed to neutral followed by cannabis or tobacco cues in a fixed sequence while they answer questions about their subjective state. The cues will include everyday items (e.g., eraser) and cannabis-related items (e.g., lighter). |
Esito primario
| Misure di esito | Descrizione della misura | Arco temporale |
|---|---|---|
Change in self-reported cannabis craving | This study utilizes a structured cannabis cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Cannabis craving will be assessed following neutral cue exposure and then cannabis cue exposure. The primary outcome will be change in cannabis craving. | Up to 40 days post-baseline session |
Change in self-reported tobacco craving | This study utilizes a structured tobacco cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Tobacco craving will be assessed following neutral cue exposure and then tobacco cue exposure. The primary outcome will be change in tobacco craving. | Up to 40 days post-baseline session |
Assistente alla partecipazione
Criteri di eleggibilità
Età idonea
Adulto
Età minima
18 Years
Sessi idonei
Tutti
Accetta volontari sani
Sì
- Males/females who are 18 to 25 years of age
- Young adults who currently smoke commercial tobacco cigarettes (≥1x weekly in the past 30 days and for the past six months)
- Young adults who currently smoke marijuana (≥4 times in past 30 days and at least weekly on average for the last six months)
- Participants must report purchasing their own tobacco and marijuana at least once in the past 6 months
- Participants must speak, comprehend, and read English.
- Intention to quit marijuana or tobacco use in the next 30 days
- Self-reported illicit drug or heavy episodic alcohol use on >20 days in the past month (excluding marijuana)
- Individuals who are pregnant or breastfeeding
- Positive saliva test for recent THC use
- Breath alcohol level above 0 at any session.
- Participants who exclusively roll their own tobacco cigarettes
National Institutes of Health (NIH)
Istituto nazionale dei tumori, Estados Unidos
Contatti principali dello studio
Contatto: Elizabeth Aston, PhD, 401-863-6668, [email protected]
1 Centri dello studio in 1 paesi
Rhode Island
Brown University School of Public Health, Providence, Rhode Island, 02903, United States
Elizabeth Aston, PhD, Contatto, 401-863-6668, [email protected]
In arruolamento